APA-referens

Rhee, S. Y. (2020). Letter: Favorable Glycemic Control with Once-Daily Insulin Degludec/Insulin Aspart after Changing from Basal Insulin in Adults with Type 2 Diabetes (Endocrinol Metab 2019; 34:382-9, Han Na Jang et al.). Endocrinol Metab (Seoul).

Chicago-stil citat

Rhee, Sang Youl. "Letter: Favorable Glycemic Control With Once-Daily Insulin Degludec/Insulin Aspart After Changing From Basal Insulin in Adults With Type 2 Diabetes (Endocrinol Metab 2019; 34:382-9, Han Na Jang Et Al.)." Endocrinol Metab (Seoul) 2020.

MLA-referens

Rhee, Sang Youl. "Letter: Favorable Glycemic Control With Once-Daily Insulin Degludec/Insulin Aspart After Changing From Basal Insulin in Adults With Type 2 Diabetes (Endocrinol Metab 2019; 34:382-9, Han Na Jang Et Al.)." Endocrinol Metab (Seoul) 2020.

Varning: dessa hänvisningar är inte alltid fullständigt riktiga.